Abstract
Common fragile sites (CFSs) are genomic regions prone to breakage under replication stress conditions recurrently rearranged in cancer. Many CFSs are enriched with AT-dinucleotide rich sequences (AT-DRSs) which have the potential to form stable secondary structures upon unwinding the double helix during DNA replication. These stable structures can potentially perturb DNA replication progression, leading to genomic instability. Using site-specific targeting system, we show that targeted integration of a 3.4 kb AT-DRS derived from the human CFS FRA16C into a chromosomally stable region within the human genome is able to drive fragile site formation under conditions of replication stress. Analysis of >1300 X chromosomes integrated with the 3.4 kb AT-DRS revealed recurrent gaps and breaks at the integration site. DNA sequences derived from the integrated AT-DRS showed in vitro a significantly increased tendency to fold into branched secondary structures, supporting the predicted mechanism of instability. Our findings clearly indicate that intrinsic DNA features, such as complexed repeated sequence motifs, predispose the human genome to chromosomal instability.
Original language | English |
---|---|
Pages (from-to) | 9685-9695 |
Number of pages | 11 |
Journal | Nucleic Acids Research |
Volume | 47 |
Issue number | 18 |
DOIs | |
State | Published - 10 Oct 2019 |
Bibliographical note
Publisher Copyright:© The Author(s) 2019
Funding
Israel Science Foundation [176/11 to B.K.]; The Chief Scientist Office of the Israel Ministry of Health [3-00000-6014 to B.K.]; The Israel Science Foundation and the National Natural Science Foundation of China (NSFC-ISF) Joint Research Program [2535/16 to B.K.]; Israeli Centers for Research Excellence (I-CORE), Gene Regulation in Complex Human Disease [41/11 to B.K.]; NIH [RO1GM101192 to Y.H.W.]. Funding for open access charge: ISF. Conflict of interest statement. None declared.
Funders | Funder number |
---|---|
Gene Regulation in Complex Human Disease | 41/11 |
NSFC-ISF | 2535/16 |
National Institutes of Health | |
National Institute of General Medical Sciences | R01GM101192 |
National Natural Science Foundation of China | |
Israel Science Foundation | 176/11 |
Israeli Centers for Research Excellence | |
Office of the Chief Scientist, Ministry of Health | 3-00000-6014 |